Featured Research

from universities, journals, and other organizations

Antiprotons Four Times More Effective Than Protons For Cell Irradiation

Date:
November 2, 2006
Source:
CERN
Summary:
A pioneering experiment at CERN with potential future application in cancer therapy has produced its first results. Started in 2003, ACE (Antiproton Cell Experiment) is the first investigation of the biological effects of antiprotons.

The ACE experiment investigates the effect of antiprotons on cell irradiation. From left to right: Michael Holzscheiter with Niels Bassler and Helge Knudsen in front of the ACE experiment. The particle beam enters a tube of cells in the centre of a tank containing a solution of glycerol and water.
Credit: Image courtesy of CERN

A pioneering experiment at CERN with potential future application in cancer therapy has produced its first results. Started in 2003, ACE (Antiproton Cell Experiment) is the first investigation of the biological effects of antiprotons.

"We have taken the first step towards a novel treatment for cancer. The results show that antiprotons are four times more effective than protons at terminating live cells. Although it still has to be compared with other existing methods, it is a breakthrough in this area of investigation." says Michael Doser at CERN, one of the scientists collaborating on the experiment. ACE brings together a team of experts in the fields of physics, biology, and medicine from 10 institutes around the world.

Current particle beam therapy commonly uses protons to destroy tumour cells inside a patient. The ACE experiment directly compared the effectiveness of cell irradiation using protons and antiprotons. To simulate a cross-section of tissue inside a body, tubes were filled with hamster cells suspended in gelatine. Researchers sent a beam of protons or antiprotons with a range of 2 cm depth into one end of the tube, and evaluated the fraction of surviving cells after irradiation along the path of the beam.

The results showed that antiprotons were four times more effective than protons. When comparing a beam of antiprotons with a beam of protons that cause identical damage at the entrance to the target, the experiment found the damage to cells inflicted at the end of the beam path to be four times higher for antiprotons than for protons. Michael Holzscheiter, spokesperson of the ACE experiment, summarises: "To achieve the same level of damage to cells at the target area one needs four times fewer antiprotons than protons. This significantly reduces the damage to the cells along the entrance channel of the beam for antiprotons compared to protons. Due to the antiproton's unsurpassed ability to preserve healthy tissue while causing damage to a specific area, this type of beam could be highly valuable in treating cases of recurring cancer, where this property is vital."

Antiprotons are antimatter; they have to be produced in small amounts in a laboratory with the help of a particle accelerator. When matter and antimatter particles meet, they annihilate, or destroy each other, transforming their mass into energy. The experiment makes use of this property as the antiproton would annihilate with a part of the nucleus of an atom in a tumour cell. The fragments produced from the energy released by the annihilation would be projected into adjacent tumour cells, which are in turn destroyed.

"CERN is a unique facility for this work. It is the only place in the world where an antiproton beam of sufficiently low energy and high quality is available. This is crucial for our research. Without access to the antiproton decelerator facility, these experiments would simply not have been possible." says Niels Bassler, co-spokesperson of ACE. "This experiment is a fantastic example of how research in particle physics can generate innovative solutions with potential medical benefits."

Researchers are currently conducting more tests to irradiate cells at a greater depth (about 15cm below the surface). Experiments to compare the effectiveness of antiprotons with another form of treatment using carbon ions will begin next month at GSI (Gesellschaft fόr Schwerionenforschung) in Germany. Further tests are planned to fully assess the effectiveness and suitability of antiprotons for cancer therapy, and to assure that less damage is caused to healthy tissues compared to other methods.

If all goes well, the first clinical application would still be a decade or more into the future.

Full results of the experiment are published today in Radiotherapy and Oncology -- Journal of the European Society for Therapeutic Radiology and Oncology. Holzscheiter MH et al., The Biological Effectiveness of Antiproton Irradiation, Radiother Oncol (2006), doi:10.1016/j.radonc.2006.09.012


Story Source:

The above story is based on materials provided by CERN. Note: Materials may be edited for content and length.


Cite This Page:

CERN. "Antiprotons Four Times More Effective Than Protons For Cell Irradiation." ScienceDaily. ScienceDaily, 2 November 2006. <www.sciencedaily.com/releases/2006/10/061031141340.htm>.
CERN. (2006, November 2). Antiprotons Four Times More Effective Than Protons For Cell Irradiation. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/2006/10/061031141340.htm
CERN. "Antiprotons Four Times More Effective Than Protons For Cell Irradiation." ScienceDaily. www.sciencedaily.com/releases/2006/10/061031141340.htm (accessed April 23, 2014).

Share This



More Matter & Energy News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Air Force: $4.2B Saved from Grounding A-10s

Air Force: $4.2B Saved from Grounding A-10s

AP (Apr. 23, 2014) — Speaking about the future of the United States Air Force, Chief of Staff Gen. Mark Welsh says the choice to divest the A-10 fleet was logical and least impactful. (April 23) Video provided by AP
Powered by NewsLook.com
Is North Korea Planning Nuclear Test #4?

Is North Korea Planning Nuclear Test #4?

Newsy (Apr. 22, 2014) — South Korean officials say North Korea is preparing to conduct another nuclear test, but is Pyongyang just bluffing this time? Video provided by Newsy
Powered by NewsLook.com
China Falls for 4x4s at Beijing Auto Show

China Falls for 4x4s at Beijing Auto Show

AFP (Apr. 22, 2014) — The urban 4x4 is the latest must-have for Chinese drivers, whose conversion to the cult of the SUV is the talking point of this year's Beijing auto show. Duration: 00:40 Video provided by AFP
Powered by NewsLook.com
Hagel Gets Preview of New High-Tech Projects

Hagel Gets Preview of New High-Tech Projects

AP (Apr. 22, 2014) — Defense Secretary Chuck Hagel is given hands-on demonstrations Tuesday of some of the newest research from DARPA _ the military's Defense Advanced Research Projects Agency program. (April 22) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins